TomoSeq data search

Data search

Results for MligTC455_33222

Cluster	Total UMI counts	Global CPM	Transcripts	Categories	Human homolog	Annotation
MligTC455_33222	8	0.16	Mlig455_018681, Mlig455_051594, Mlig455_064898	Neo: - Age: -	HMCN1, HMCN2	Mlig455_018681 {REF} {Length: 3884} {Pfam: Immunoglobulin domain [PF13927.8, score=346.4]; Immunoglobulin I-set domain [PF07679.18, score=332.3]; Immunoglobulin domain [PF00047.27, score=226.0]; Immunoglobulin domain [PF13895.8, score=216.4]; Immunoglobulin V-set domain [PF07686.19, score=106.8]; Immunoglobulin domain [PF18452.3, score=55.5]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=52.0]; Natural killer cell receptor 2B4 [PF11465.10, score=39.6]; Izumo-like Immunoglobulin domain [PF16706.7, score=34.8]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=30.6]; CD47 immunoglobulin-like domain [PF08204.13, score=24.7]; Immunoglobulin C2-set domain [PF05790.17, score=21.7]; Adenovirus E3 region protein CR1 [PF02440.17, score=21.6]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=257, Expect=1e-68]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=239, Expect=2e-63]} {Dmel: FBgn0033159, Dscam1, Down syndrome cell adhesion molecule 1, [Score=120, Expect=6e-27]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=219, Expect=4e-57]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=202, Expect=5e-52]} {RNA1509_30589} {RNA1310_15139} {RNA815_21761} Mlig455_051594 {REF} {Length: 8310} {Pfam: Immunoglobulin domain [PF13927.8, score=576.1]; Immunoglobulin I-set domain [PF07679.18, score=564.8]; Immunoglobulin domain [PF13895.8, score=397.8]; Immunoglobulin domain [PF00047.27, score=372.5]; Immunoglobulin V-set domain [PF07686.19, score=151.1]; Immunoglobulin domain [PF18452.3, score=95.1]; Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain [PF16681.7, score=84.6]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=73.9]; Natural killer cell receptor 2B4 [PF11465.10, score=56.4]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=53.9]; Izumo-like Immunoglobulin domain [PF16706.7, score=43.7]; Immunoglobulin C2-set domain [PF05790.17, score=43.1]; CD47 immunoglobulin-like domain [PF08204.13, score=41.9]; C17orf99 Ig domain [PF17736.3, score=35.1]; Adenovirus E3 region protein CR1 [PF02440.17, score=28.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=607, Expect=2e-178]; ENSG00000143341, HMCN1, hemicentin 1, [Score=578, Expect=4e-169]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=586, Expect=6e-172]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=568, Expect=8e-166]} {Dmel: FBgn0053519, Unc-89, [Score=168, Expect=4e-41]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=528, Expect=5e-153]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=551, Expect=1e-160]} {RNA1509_30589} {RNA1310_15139, RNA1509_30589} {RNA1509_30589, RNA815_21761} Mlig455_064898 {REF} {Length: 3566} {Pfam: Immunoglobulin domain [PF13927.8, score=317.4]; Immunoglobulin I-set domain [PF07679.18, score=294.3]; Immunoglobulin domain [PF00047.27, score=214.6]; Immunoglobulin domain [PF13895.8, score=206.0]; Immunoglobulin V-set domain [PF07686.19, score=97.6]; Immunoglobulin domain [PF18452.3, score=57.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=45.2]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=35.3]; Izumo-like Immunoglobulin domain [PF16706.7, score=34.1]; Natural killer cell receptor 2B4 [PF11465.10, score=33.0]; C17orf99 Ig domain [PF17736.3, score=30.5]; Immunoglobulin C2-set domain [PF05790.17, score=26.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=256, Expect=1e-69]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=248, Expect=3e-67]} {Dmel: FBgn0265296, Dscam2, Down syndrome cell adhesion molecule 2, [Score=131, Expect=2e-30]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=208, Expect=1e-54]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=191, Expect=2e-49]} {RNA1509_30589} {RNA1310_15139} {RNA815_21761}

Cluster

Total UMI counts

Global CPM

Transcripts

Categories

Human homolog

Annotation

MligTC455_33222

0.16

Mlig455_018681, Mlig455_051594, Mlig455_064898

Neo: -

Age: -

HMCN1, HMCN2

Mlig455_018681 {REF} {Length: 3884} {Pfam: Immunoglobulin domain [PF13927.8, score=346.4]; Immunoglobulin I-set domain [PF07679.18, score=332.3]; Immunoglobulin domain [PF00047.27, score=226.0]; Immunoglobulin domain [PF13895.8, score=216.4]; Immunoglobulin V-set domain [PF07686.19, score=106.8]; Immunoglobulin domain [PF18452.3, score=55.5]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=52.0]; Natural killer cell receptor 2B4 [PF11465.10, score=39.6]; Izumo-like Immunoglobulin domain [PF16706.7, score=34.8]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=30.6]; CD47 immunoglobulin-like domain [PF08204.13, score=24.7]; Immunoglobulin C2-set domain [PF05790.17, score=21.7]; Adenovirus E3 region protein CR1 [PF02440.17, score=21.6]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=257, Expect=1e-68]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=239, Expect=2e-63]} {Dmel: FBgn0033159, Dscam1, Down syndrome cell adhesion molecule 1, [Score=120, Expect=6e-27]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=219, Expect=4e-57]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=202, Expect=5e-52]} {RNA1509_30589} {RNA1310_15139} {RNA815_21761}

Mlig455_051594 {REF} {Length: 8310} {Pfam: Immunoglobulin domain [PF13927.8, score=576.1]; Immunoglobulin I-set domain [PF07679.18, score=564.8]; Immunoglobulin domain [PF13895.8, score=397.8]; Immunoglobulin domain [PF00047.27, score=372.5]; Immunoglobulin V-set domain [PF07686.19, score=151.1]; Immunoglobulin domain [PF18452.3, score=95.1]; Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain [PF16681.7, score=84.6]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=73.9]; Natural killer cell receptor 2B4 [PF11465.10, score=56.4]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=53.9]; Izumo-like Immunoglobulin domain [PF16706.7, score=43.7]; Immunoglobulin C2-set domain [PF05790.17, score=43.1]; CD47 immunoglobulin-like domain [PF08204.13, score=41.9]; C17orf99 Ig domain [PF17736.3, score=35.1]; Adenovirus E3 region protein CR1 [PF02440.17, score=28.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=607, Expect=2e-178]; ENSG00000143341, HMCN1, hemicentin 1, [Score=578, Expect=4e-169]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=586, Expect=6e-172]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=568, Expect=8e-166]} {Dmel: FBgn0053519, Unc-89, [Score=168, Expect=4e-41]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=528, Expect=5e-153]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=551, Expect=1e-160]} {RNA1509_30589} {RNA1310_15139, RNA1509_30589} {RNA1509_30589, RNA815_21761}

Mlig455_064898 {REF} {Length: 3566} {Pfam: Immunoglobulin domain [PF13927.8, score=317.4]; Immunoglobulin I-set domain [PF07679.18, score=294.3]; Immunoglobulin domain [PF00047.27, score=214.6]; Immunoglobulin domain [PF13895.8, score=206.0]; Immunoglobulin V-set domain [PF07686.19, score=97.6]; Immunoglobulin domain [PF18452.3, score=57.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=45.2]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=35.3]; Izumo-like Immunoglobulin domain [PF16706.7, score=34.1]; Natural killer cell receptor 2B4 [PF11465.10, score=33.0]; C17orf99 Ig domain [PF17736.3, score=30.5]; Immunoglobulin C2-set domain [PF05790.17, score=26.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=256, Expect=1e-69]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=248, Expect=3e-67]} {Dmel: FBgn0265296, Dscam2, Down syndrome cell adhesion molecule 2, [Score=131, Expect=2e-30]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=208, Expect=1e-54]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=191, Expect=2e-49]} {RNA1509_30589} {RNA1310_15139} {RNA815_21761}

Cumulative graph for MligTC455_33222

Region-enriched expression

Region	logFC	logCPM	Pvalue	FDR
RegionR1	0.336	0.592	1.00000	1.00000
RegionR2	0.499	0.592	0.99995	1.00000
RegionR3	-0.289	0.592	0.99993	1.00000
RegionR4	-1.055	0.592	1.00000	1.00000
RegionR5	-0.883	0.592	0.99997	1.00000
RegionR6	-0.755	0.592	0.99997	1.00000
RegionR7	0.6	0.592	1.00000	1.00000
RegionR8	1.546	0.592	0.99994	1.00000

Regeneration-enriched expression

Region	logFC	logCPM	PValue	FDR
RegenerationR1	-1.289	0.592	0.99996	1.00000
RegenerationR2	1.105	0.592	0.99955	1.00000
RegenerationR3	0.377	0.592	1.00000	1.00000
RegenerationR4	-0.634	0.592	0.99995	1.00000
RegenerationR5	2.233	0.592	0.99967	1.00000
RegenerationR6	-0.718	0.592	0.99998	1.00000
RegenerationBL	1.849	0.592	0.99993	1.00000
RegenerationTP	-1.166	0.592	1.00000	1.00000

Genes with expression patterns similar to MligTC455_33222

Nr.	Cluster	Total UMI counts	Global CPM	Transcripts	Categories	Human homolog	Σ Spearman correlations	Int1	Int2	Int3	Reg1	Reg2	Reg3	Annotation
1.	MligTC455_33222	8	0.16	Mlig455_018681, Mlig455_051594, Mlig455_064898	Neo: - Age: -	HMCN1, HMCN2	1	-	-	-	-	1.000	-	Mlig455_018681 {REF} {Length: 3884} {Pfam: Immunoglobulin domain [PF13927.8, score=346.4]; Immunoglobulin I-set domain [PF07679.18, score=332.3]; Immunoglobulin domain [PF00047.27, score=226.0]; Immunoglobulin domain [PF13895.8, score=216.4]; Immunoglobulin V-set domain [PF07686.19, score=106.8]; Immunoglobulin domain [PF18452.3, score=55.5]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=52.0]; Natural killer cell receptor 2B4 [PF11465.10, score=39.6]; Izumo-like Immunoglobulin domain [PF16706.7, score=34.8]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=30.6]; CD47 immunoglobulin-like domain [PF08204.13, score=24.7]; Immunoglobulin C2-set domain [PF05790.17, score=21.7]; Adenovirus E3 region protein CR1 [PF02440.17, score=21.6]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=257, Expect=1e-68]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=239, Expect=2e-63]} {Dmel: FBgn0033159, Dscam1, Down syndrome cell adhesion molecule 1, [Score=120, Expect=6e-27]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=219, Expect=4e-57]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=202, Expect=5e-52]} {RNA1509_30589} {RNA1310_15139} {RNA815_21761} Mlig455_051594 {REF} {Length: 8310} {Pfam: Immunoglobulin domain [PF13927.8, score=576.1]; Immunoglobulin I-set domain [PF07679.18, score=564.8]; Immunoglobulin domain [PF13895.8, score=397.8]; Immunoglobulin domain [PF00047.27, score=372.5]; Immunoglobulin V-set domain [PF07686.19, score=151.1]; Immunoglobulin domain [PF18452.3, score=95.1]; Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain [PF16681.7, score=84.6]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=73.9]; Natural killer cell receptor 2B4 [PF11465.10, score=56.4]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=53.9]; Izumo-like Immunoglobulin domain [PF16706.7, score=43.7]; Immunoglobulin C2-set domain [PF05790.17, score=43.1]; CD47 immunoglobulin-like domain [PF08204.13, score=41.9]; C17orf99 Ig domain [PF17736.3, score=35.1]; Adenovirus E3 region protein CR1 [PF02440.17, score=28.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=607, Expect=2e-178]; ENSG00000143341, HMCN1, hemicentin 1, [Score=578, Expect=4e-169]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=586, Expect=6e-172]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=568, Expect=8e-166]} {Dmel: FBgn0053519, Unc-89, [Score=168, Expect=4e-41]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=528, Expect=5e-153]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=551, Expect=1e-160]} {RNA1509_30589} {RNA1310_15139, RNA1509_30589} {RNA1509_30589, RNA815_21761} Mlig455_064898 {REF} {Length: 3566} {Pfam: Immunoglobulin domain [PF13927.8, score=317.4]; Immunoglobulin I-set domain [PF07679.18, score=294.3]; Immunoglobulin domain [PF00047.27, score=214.6]; Immunoglobulin domain [PF13895.8, score=206.0]; Immunoglobulin V-set domain [PF07686.19, score=97.6]; Immunoglobulin domain [PF18452.3, score=57.1]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=45.2]; T-cell surface glycoprotein CD3 delta chain [PF16680.7, score=35.3]; Izumo-like Immunoglobulin domain [PF16706.7, score=34.1]; Natural killer cell receptor 2B4 [PF11465.10, score=33.0]; C17orf99 Ig domain [PF17736.3, score=30.5]; Immunoglobulin C2-set domain [PF05790.17, score=26.8]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=256, Expect=1e-69]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=248, Expect=3e-67]} {Dmel: FBgn0265296, Dscam2, Down syndrome cell adhesion molecule 2, [Score=131, Expect=2e-30]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=208, Expect=1e-54]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=191, Expect=2e-49]} {RNA1509_30589} {RNA1310_15139} {RNA815_21761}
2.	MligTC455_23921	39	0.82	Mlig455_001745	Neo: - Age: Down-Down-Up		0.957	-	-	-	-	0.957	-	Mlig455_001745 {REF} {Length: 6132} {Pfam: AMP-binding enzyme [PF00501.30, score=70.6]} {RNA1509_37800} {RNA1310_40483, RNA1509_37800} {RNA1509_37800, RNA815_42562}

Nr.

Cluster

Total UMI counts

Global CPM

Transcripts